以误导性财务报表为由,就证券欺诈对Organ & Co.提起了集团诉讼。 Class-action lawsuit filed against Organon & Co. for securities fraud, citing misleading financial statements.

对Organ & Co.提起了集体诉讼,指控从2024年10月31日至2025年4月30日证券欺诈。 A class-action lawsuit has been filed against Organon & Co., alleging securities fraud from October 31, 2024, to April 30, 2025. 诉讼称该公司对其资本配置和股息策略做出了误导性陈述,导致季度股息减少70%,股价下跌27%. The lawsuit claims the company made misleading statements about its capital allocation and dividend strategies, leading to a 70% cut in quarterly dividends and a 27% drop in stock price. 损失超过100 000美元的股东可在2025年7月22日之前加入诉讼。 Shareholders with losses exceeding $100,000 can join the lawsuit by July 22, 2025. 几家律师事务所代表了受影响的投资者。 Several law firms are representing affected investors.